Efficacy of Pandughni Vati & Punarnavadi Mandura Vati in the managment of Pandu w.s.r. iron deficiency anemia in children- An open labelled comparative clinical trial.

Ayu Pub Date : 2020-10-01 Epub Date: 2022-06-03 DOI:10.4103/ayu.AYU_206_20
V K Kori, K S Patel
{"title":"Efficacy of <i>Pandughni Vati</i> & <i>Punarnavadi Mandura Vati</i> in the managment of <i>Pandu</i> w.s.r. iron deficiency anemia in children- An open labelled comparative clinical trial.","authors":"V K Kori,&nbsp;K S Patel","doi":"10.4103/ayu.AYU_206_20","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Anemia is a public health problem worldwide, and its prevalence in India is higher than any other south asian countries. Iron deficiency anemia (IDA) is having larger share out of all types of anaemia's. Symptomatology of IDA resembles with <i>Kapha</i> dominant variety of <i>Pandu</i>. <i>Pandughni</i> <i>Vati</i> (PV) and <i>Punarnavadi</i> <i>Mandura</i> (PM) <i>Vati</i> mentioned in Ayurveda are being used in clinical practice since long.</p><p><strong>Aim: </strong>To assess the efficacy of <i>Pandughni</i> <i>Vati</i> and compare its clinical efficacy with <i>Punarnavadi Mandura Vati</i> in the management of <i>Pandu</i> ws.r. iron deficiency anemia in children.</p><p><strong>Materials and methods: </strong>Present clinical study was a randomized trial for management of iron deficiency anemia aged 2-16 years. Out of total 91 patients enrolled, 60 completed the study and divided into two groups. In group A, <i>Pandughni Vati</i> (trial drug) and in group B, <i>Punarnavadi Mandura Vati</i> in the management of <i>Pandu</i> ws.r. iron deficiency anemia in children. (standard drug) were given to 30-30 patients respectively for a duration of 90 days in age specific doses. Patients were assessed by clinical signs and symptoms of <i>Pandu</i> and investigation parameters like complete blood count, serum iron, serum ferritin and total iron binding capacity (TIBC) on baseline and after 90 days of treatment. Statistical analysis was carried out by Sigma Stat software.</p><p><strong>Results: </strong>On comparison, highly significant difference was found between two groups in subjective parameters such as <i>Panduta</i> (pallor), <i>Daurbalya</i> (weakness), <i>Hriddrava</i> (palpitation), <i>Akshikuta Shotha</i> (periorbital oedema), <i>Pindikodweshtana</i> (leg cramps) and <i>Shwasa</i> (breathlessness) whereas objective and saturation percentage except serum ferritin.</p><p><strong>Conclusion: </strong>The study revealed that, both the drugs; <i>Pandughni Vati</i> and <i>Punarnavadi Mandura Vati</i> were equally effective in the management of IDA so, it could be concluded that <i>Pandughni Vati</i>, can be used as mineral-free, safe, easily obtainable, palatable, cost-effective alternative drug of choice in alternative of <i>Punarnavadi Mandura</i> in iron deficiency anemia in children.</p>","PeriodicalId":8720,"journal":{"name":"Ayu","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4d/4a/AYU-41-218.PMC9261995.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ayu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ayu.AYU_206_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Anemia is a public health problem worldwide, and its prevalence in India is higher than any other south asian countries. Iron deficiency anemia (IDA) is having larger share out of all types of anaemia's. Symptomatology of IDA resembles with Kapha dominant variety of Pandu. Pandughni Vati (PV) and Punarnavadi Mandura (PM) Vati mentioned in Ayurveda are being used in clinical practice since long.

Aim: To assess the efficacy of Pandughni Vati and compare its clinical efficacy with Punarnavadi Mandura Vati in the management of Pandu ws.r. iron deficiency anemia in children.

Materials and methods: Present clinical study was a randomized trial for management of iron deficiency anemia aged 2-16 years. Out of total 91 patients enrolled, 60 completed the study and divided into two groups. In group A, Pandughni Vati (trial drug) and in group B, Punarnavadi Mandura Vati in the management of Pandu ws.r. iron deficiency anemia in children. (standard drug) were given to 30-30 patients respectively for a duration of 90 days in age specific doses. Patients were assessed by clinical signs and symptoms of Pandu and investigation parameters like complete blood count, serum iron, serum ferritin and total iron binding capacity (TIBC) on baseline and after 90 days of treatment. Statistical analysis was carried out by Sigma Stat software.

Results: On comparison, highly significant difference was found between two groups in subjective parameters such as Panduta (pallor), Daurbalya (weakness), Hriddrava (palpitation), Akshikuta Shotha (periorbital oedema), Pindikodweshtana (leg cramps) and Shwasa (breathlessness) whereas objective and saturation percentage except serum ferritin.

Conclusion: The study revealed that, both the drugs; Pandughni Vati and Punarnavadi Mandura Vati were equally effective in the management of IDA so, it could be concluded that Pandughni Vati, can be used as mineral-free, safe, easily obtainable, palatable, cost-effective alternative drug of choice in alternative of Punarnavadi Mandura in iron deficiency anemia in children.

Abstract Image

Abstract Image

Pandughni Vati和Punarnavadi Mandura Vati治疗儿童Pandu w.s.r.缺铁性贫血的疗效-一项开放标记的比较临床试验。
背景:贫血是一个全球性的公共卫生问题,其在印度的患病率高于任何其他南亚国家。缺铁性贫血(IDA)在所有类型的贫血中所占的比例较大。IDA的症状类似于Kapha优势型Pandu。阿育吠陀中提到的Pandughni Vati (PV)和Punarnavadi Mandura (PM) Vati长期以来一直用于临床实践。目的:评价Pandughni Vati的疗效,并比较其与Punarnavadi Mandura Vati治疗Pandu wr的临床疗效。儿童缺铁性贫血。材料和方法:本临床研究是一项2-16岁儿童缺铁性贫血治疗的随机试验。在总共91名入组患者中,60名完成了研究并被分为两组。A组使用Pandughni Vati(试验药物),B组使用Punarnavadi Mandura Vati治疗Pandu。儿童缺铁性贫血。(标准药物)分别给予30-30例患者,按年龄给药,疗程90天。在治疗前和治疗90 d后,通过Pandu的临床体征和症状以及全血细胞计数、血清铁、血清铁蛋白和总铁结合能力(TIBC)等调查参数对患者进行评估。采用Sigma Stat软件进行统计分析。结果:两组患者除血清铁蛋白外,在主观指标Panduta(苍白)、Daurbalya(虚弱)、Hriddrava(心悸)、Akshikuta Shotha(眶周水肿)、Pindikodweshtana(腿部痉挛)、Shwasa(呼吸困难)等方面均存在显著差异。结论:研究表明,两种药物;Pandughni Vati和Punarnavadi Mandura Vati对IDA的治疗效果相同,因此,Pandughni Vati可以作为无矿物质、安全、易于获得、可口、经济的替代药物,作为Punarnavadi Mandura的替代药物,用于儿童缺铁性贫血。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ayu
Ayu
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信